Becton Dickinson and Co
BDX179.380USD
-2.140-1.18%
收盤 10/30, 16:00（美東）報價延遲15分鐘
51.42B總市值
32.44本益比TTM
關於 Becton Dickinson and Co 公司
碧迪醫療是一家全球醫療技術公司。該公司從事醫療機構、醫生、生命科學研究人員、臨牀實驗室等使用的各種醫療用品、設備、實驗室設備和診斷產品的開發、製造和銷售。其 BD 醫療部門生產一系列醫療技術和設備，用於幫助改善各種環境中的醫療服務。BD 醫療部門由多個業務部門組成，包括藥物輸送解決方案、藥物管理解決方案、高級監控和製藥系統。其 BD 生命科學部門提供用於收集和運輸診斷樣本的產品，以及用於檢測各種傳染病、醫療相關感染和癌症的儀器和試劑系統。其 BD 介入部門提供血管、泌尿科、腫瘤科和外科專業產品。
Becton Dickinson and Co簡介
公司代碼BDX
公司名稱Becton Dickinson and Co
上市日期Sep 25, 1963
CEOMr. Thomas E. Polen
員工數量74000
證券類型Ordinary Share
年結日Sep 25
公司地址One Becton Drive
城市FRANKLIN LAKES
上市交易所NYSE Consolidated
國家United States of America
郵編07417-1880
電話12018476800
網址https://www.bd.com/
公司代碼BDX
上市日期Sep 25, 1963
CEOMr. Thomas E. Polen
Becton Dickinson and Co公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.43K
-0.03%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
8.25K
-0.69%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
6.05K
+659.55%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.43K
-0.03%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Medication Delivery Solutions
1.13B
20.55%
Medication Management Solutions
888.00M
16.12%
Pharmaceutical Systems
629.00M
11.42%
Peripheral Intervention
512.00M
9.29%
Specimen Management
470.00M
8.53%
其他
1.88B
34.09%
地區USD
名稱
營收
佔比
United States
3.18B
57.72%
International
2.33B
42.26%
業務
地區
業務USD
名稱
營收
佔比
Medication Delivery Solutions
1.13B
20.55%
Medication Management Solutions
888.00M
16.12%
Pharmaceutical Systems
629.00M
11.42%
Peripheral Intervention
512.00M
9.29%
Specimen Management
470.00M
8.53%
其他
1.88B
34.09%
股東統計
更新時間: 9月16日 週二
更新時間: 9月16日 週二
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.22%
T. Rowe Price Investment Management, Inc.
5.64%
BlackRock Institutional Trust Company, N.A.
5.29%
State Street Investment Management (US)
4.68%
First Eagle Investment Management, L.L.C.
3.07%
其他
70.10%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.22%
T. Rowe Price Investment Management, Inc.
5.64%
BlackRock Institutional Trust Company, N.A.
5.29%
State Street Investment Management (US)
4.68%
First Eagle Investment Management, L.L.C.
3.07%
其他
70.10%
股東類型
持股股東
佔比
Investment Advisor
49.19%
Investment Advisor/Hedge Fund
31.30%
Hedge Fund
3.64%
Research Firm
2.95%
Pension Fund
2.12%
Bank and Trust
1.72%
Sovereign Wealth Fund
1.38%
Individual Investor
0.57%
Insurance Company
0.32%
其他
6.79%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
2819
264.75M
92.37%
-12.47M
2025Q2
2864
264.72M
92.36%
-14.86M
2025Q1
2897
269.10M
93.89%
-12.90M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
32.17M
11.22%
+4.30M
+15.41%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
16.18M
5.64%
+3.60M
+28.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
15.15M
5.29%
+360.45K
+2.44%
Jun 30, 2025
State Street Investment Management (US)
13.41M
4.68%
-579.46K
-4.14%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
8.79M
3.07%
+3.27M
+59.18%
Jun 30, 2025
T. Rowe Price Associates, Inc.
8.47M
2.95%
-2.43M
-22.27%
Jun 30, 2025
MFS Investment Management
7.69M
2.68%
+1.58M
+25.78%
Jun 30, 2025
Geode Capital Management, L.L.C.
6.72M
2.35%
+244.20K
+3.77%
Jun 30, 2025
ClearBridge Investments, LLC
3.80M
1.33%
+321.67K
+9.24%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
3.79M
1.32%
+551.15K
+17.00%
Jun 30, 2025
查看更多
持股ETF
更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
iShares U.S. Medical Devices ETF
4.96%
American Century Focused Large Cap Value ETF
3.06%
Franklin ClearBridge Enhanced Income ETF
2.85%
T Rowe Price Capital Appreciation Equity ETF
2.79%
iShares Large Cap Value Active ETF
2.61%
First Eagle Global Equity ETF
2.6%
Monarch Volume Factor Dividend Tree Index ETF
2.41%
Brandes US Value ETF
2.21%
SPDR S&P Health Care Equipment ETF
2.02%
Running Oak Efficient Growth ETF
2.02%
查看更多
iShares U.S. Medical Devices ETF
佔比4.96%
American Century Focused Large Cap Value ETF
佔比3.06%
Franklin ClearBridge Enhanced Income ETF
佔比2.85%
T Rowe Price Capital Appreciation Equity ETF
佔比2.79%
iShares Large Cap Value Active ETF
佔比2.61%
First Eagle Global Equity ETF
佔比2.6%
Monarch Volume Factor Dividend Tree Index ETF
佔比2.41%
Brandes US Value ETF
佔比2.21%
SPDR S&P Health Care Equipment ETF
佔比2.02%
Running Oak Efficient Growth ETF
佔比2.02%
分紅派息
近5年累計派現
5.34B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
